Literature DB >> 1370074

Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids.

L Pirisi1, A Batova, G R Jenkins, J R Hodam, K E Creek.   

Abstract

Human papillomavirus (HPV) type 16 (HPV16) is associated with a large percentage of cervical malignancies, and HPV16 DNA can immortalize human keratinocytes in vitro. The transforming ability of the virus resides primarily in the open reading frames E6 and E7. Retinoids are potent modulators of growth and differentiation of keratinocytes and have been shown to reverse cervical lesions resulting from HPV infection. We compared the sensitivity of normal human foreskin keratinocytes (HKc) and four immortalized HKc lines, independently obtained by transfection of different normal HKc strains with HPV16 DNA (HKc/HPV16), to growth control by retinoic acid (RA). All the HKc/HPV16 lines were 10- to 100-fold more sensitive than normal HKc to growth inhibition by RA in both clonal and mass culture growth assays. The precursor to RA, retinol, was also found to be a more potent inhibitor of growth of HKc/HPV16 than normal HKc, while beta-carotene did not inhibit growth of either normal HKc or HKc/HPV16. In addition, HKc/HPV16 lines were more sensitive than normal HKc to modulation of keratin expression by RA and retinol. No differences were observed in the rate of uptake of [3H]RA or [3H]retinol between normal HKc and HKc/HPV16. Dot blot analysis of RNA extracted from HKc/HPV16 cultured in the absence or in the presence of 10(-7) M RA showed that the expression of the HPV16 open reading frames E6 and E7 is reduced 2- to 4-fold by RA. In addition, Northern blot analysis demonstrated that RA inhibition of E6 and E7 expression was both dose and time dependent. Overall, these results suggest that the increased sensitivity of the HKc/HPV16 lines to growth control by RA may be mediated by an inhibition of the expression of HPV16 gene products which are required for the maintenance of continuous growth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370074

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Endogenous two-photon fluorescence imaging elucidates metabolic changes related to enhanced glycolysis and glutamine consumption in precancerous epithelial tissues.

Authors:  Antonio Varone; Joanna Xylas; Kyle P Quinn; Dimitra Pouli; Gautham Sridharan; Margaret E McLaughlin-Drubin; Carlo Alonzo; Kyongbum Lee; Karl Münger; Irene Georgakoudi
Journal:  Cancer Res       Date:  2014-03-31       Impact factor: 12.701

2.  Investigation of non-linear adaptive responses and split dose recovery induced by ionizing radiation in three human epithelial derived cell lines.

Authors:  Lorna A Ryan; Colin B Seymour; Carmel E Mothersill
Journal:  Dose Response       Date:  2009-08-06       Impact factor: 2.658

3.  Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming.

Authors:  Margaret E McLaughlin-Drubin; Christopher P Crum; Karl Münger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

4.  Phenylbutyrate inhibits growth of cervical carcinoma cells independent of HPV type and copy number.

Authors:  P Finzer; M Stöhr; N Seibert; F Rösl
Journal:  J Cancer Res Clin Oncol       Date:  2003-02-27       Impact factor: 4.553

5.  Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cells.

Authors:  Istvan Arany; William E Whitehead; Kenneth J Grattendick; Istvan A Ember; Stephen K Tyring
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

6.  Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons.

Authors:  M A Khan; W H Tolleson; J D Gangemi; L Pirisi
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Decreased serum retinol levels in women with cervical dysplasia.

Authors:  H Shimizu; C Nagata; S Komatsu; N Morita; H Higashiiwai; N Sugahara; S Hisamichi
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.